• 21 November 2017

    Can the UK stay on medicine’s cutting edge?

    Like other businesses, the healthcare sector is entering the period of digital disruption, and experts at the Pharma Integrates event held on 15-16 November in London discussed how the UK’s...

  • 15 November 2017

    MyCite: The first pill with digital tracking system

    The FDA has approved Abilify MyCite (aripiprazole) as the first drug with a digital tracking system, in a groundbreaking move that ensures patients suffering from mental illness take the medication...

  • 7 September 2017

    An update on PARP inhibitors: ovarian cancer and beyond

    On 17 August, AstraZeneca's label expansion request for its first-to-market poly (ADP-ribose) polymerase (PARP) inhibitor Lynparza (olaparib) was approved by the US Food and Drug Administration (FDA). The drug received...